Tested Applications
| Positive IHC detected in | human hepatocirrhosis tissue, human brain tissue, mouse brain tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
21160-1-AP targets ELOVL6 in IHC, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse, rat, goat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag14163 Product name: Recombinant human ELOVL6 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-80 aa of BC001305 Sequence: MNMSVLTLQEYEFEKQFNENEAIQWMQENWKKSFLFSALYAAFIFGGRHLMNKRAKFELRKPLVLWSLTLAVFSIFGALR Predict reactive species |
| Full Name | ELOVL family member 6, elongation of long chain fatty acids (FEN1/Elo2, SUR4/Elo3-like, yeast) |
| Calculated Molecular Weight | 265 aa, 31 kDa |
| GenBank Accession Number | BC001305 |
| Gene Symbol | ELOVL6 |
| Gene ID (NCBI) | 79071 |
| RRID | AB_10694572 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9H5J4 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for ELOVL6 antibody 21160-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The ELOVL6 Polyclonal antibody (Cat# 21160-1-AP) has 8 citations published in journals including J Adv Res, J Clin Invest, Clin Transl Med, Drug Des Devel Ther, Nutrients, Front Pharmacol, Biochim Biophys Acta, and Animals (Basel). Research fields span ferroptosis in neural stem cells, nonalcoholic fatty liver disease, cancer cell fatty acid metabolism, hepatic steatosis, fatty acid elongation and de novo synthesis, lipogenic transcription, and lipid metabolism in mammary glands.
| Species | Application | Title |
|---|---|---|
J Adv Res Gastrodin attenuates high fructose-induced sweet taste preference decrease by inhibiting hippocampal neural stem cell ferroptosis | ||
J Clin Invest TRIM56 protects against nonalcoholic fatty liver disease by promoting the degradation of fatty acid synthase | ||
Clin Transl Med NAT10: An RNA cytidine transferase regulates fatty acid metabolism in cancer cells | ||
Drug Des Devel Ther Selective Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Attenuates High-Fat Diet-Induced Hepatic Steatosis in Mice. | ||
Front Pharmacol Baicalein Prevents Fructose-Induced Hepatic Steatosis in Rats: In the Regulation of Fatty Acid De Novo Synthesis, Fatty Acid Elongation and Fatty Acid Oxidation. |











